episphere.github.io/appshareDev
Quarto Jonas test directly from gh-pages.
Quarto Jonas test served from appshareDev.
Quarto POSIT demo directly from gh-pages.
Quarto POSIT demo served from appshareDev.
StockAPI served by Plummer at appshareDev
Shiny portfolio served at appshareDev.
Markdown report directly from gh-pages.
Markdown report served from appshareDev.
vetiver.posit.co <--ML
Governance, app and API alike !
interoperability with NIDAP.
...
pls share your own
Do we have/need Posit Workbench?
...
...
New FAIR CIT environment, announced last week, APIs NoSQL etc
https://episphere.github.io/lab/testYjs.html
yarrayShared <-- shared object
updateYArrayShared(['not a cofeecup']) <-- sharing
yarrayShared.toJSON() <-- finding what is being shared
Signaling server implementation: https://github.com/yjs/y-webrtc/blob/master/bin/server.js
DCEG OD Seminar
Date: Thursday, April 18, 2024
Time: 10:30-11:30 AM
Location: Virtual Join Webex
Speaker: Eytan Ruppin, M.D., Ph.D.
Chief, Cancer Data Science Laboratory, Center for Cancer Research, NCI
*Dr. Ruppin bio is attached
Title: What can we learn from the good ol’ pathology slides?
Host: Stephen Chanock, M.D., Director, Division of Cancer Epidemiology and Genetics, NCI
Monday, April 15, 2024, 1:00 to 2:00pm
Masur Auditorium, NIH Clinical Center (Building 10); and NIH videocast
This special lecture in NIH's Wednesday Afternoon Lecture Series
(WALS) will be given by 2020 Nobel Prize winner Jennifer Doudna, Ph.D.,
Jennifer Doudna is a Nobel Laureate in Chemistry, and a Professor of Biochemistry, Biophysics and Structural Biology. Her research focuses on RNA as it forms a variety of complex globular structures, some of which function like enzymes or form functional complexes with proteins. Her lab's research into RNA biology led to the discovery of CRISPR-Cas9 as a tool for making targeted changes to the genome. In bacteria, CRISPR systems preserve invading genetic material and incorporate it into surveillance complexes to achieve adaptive immunity. Crystal structures of diverse Cas9 proteins reveal RNA-mediated conformational activation.
Current research in the Doudna lab focuses on discovering and determining the mechanisms of novel CRISPR-Cas and associated proteins; developing genome editing tools for use in vitro, in plants, and in mammals; and developing anti-CRISPR agents. New discoveries in this field continue at a rapid pace, revealing a technology that has widespread applications in many areas of biology.